Suppr超能文献

同型半胱氨酸是阿尔茨海默病的另一个风险因素,它会损害载脂蛋白 E3 的功能。

Homocysteine, another risk factor for Alzheimer disease, impairs apolipoprotein E3 function.

机构信息

Department of Alzheimer Disease Research, National Center for Geriatrics and Gerontology, 35 Gengo, Morioka, Obu, Aichi 474-8511, Japan.

出版信息

J Biol Chem. 2010 Dec 3;285(49):38382-8. doi: 10.1074/jbc.M110.146258. Epub 2010 Oct 1.

Abstract

Apolipoprotein E (apoE) ε4 and hyperhomocysteinemia are risk factors for Alzheimer disease (AD). The dimerization of apoE3 by disulfide bonds between cysteine residues enhances apoE3 function to generate HDL. Because homocysteine (Hcy) harbors a thiol group, we examined whether Hcy interferes with the dimerization of apoE3 and thereby impairs apoE3 function. We found that Hcy inhibits the dimerization of apoE3 and reduces apoE3-mediated HDL generation to a level similar to that by apoE4, whereas Hcy does not affect apoE4 function. Western blot analysis of cerebrospinal fluid showed that the ratio of apoE3 dimers was significantly lower in the samples from the patients with hyperhomocysteinemia than in those that from control subjects. Hyperhomocysteinemia induced by subcutaneous injection of Hcy to apoE3 knock-in mice decreased the level of the apoE3 dimer in the brain homogenate. Because apoE-HDL plays a role in amyloid β-protein clearance, these results suggest that two different risk factors, apoE4 and hyperhomocysteinemia, may share a common mechanism that accelerates the pathogenesis of AD in terms of reduced HDL generation.

摘要

载脂蛋白 E (apoE) ε4 和高同型半胱氨酸血症是阿尔茨海默病 (AD) 的危险因素。半胱氨酸残基之间的二硫键使 apoE3 二聚化,增强了 apoE3 的功能,从而产生高密度脂蛋白 (HDL)。由于同型半胱氨酸 (Hcy) 含有巯基,我们研究了 Hcy 是否会干扰 apoE3 的二聚化,从而损害 apoE3 的功能。我们发现 Hcy 抑制 apoE3 的二聚化,并降低 apoE3 介导的 HDL 生成水平,使其与 apoE4 相似,而 Hcy 不影响 apoE4 的功能。对来自高同型半胱氨酸血症患者的脑脊液的 Western blot 分析显示,apoE3 二聚体的比例明显低于对照组。apoE3 敲入小鼠皮下注射 Hcy 诱导的高同型半胱氨酸血症降低了脑匀浆中 apoE3 二聚体的水平。由于 apoE-HDL 在淀粉样β蛋白清除中发挥作用,这些结果表明,两种不同的危险因素 apoE4 和高同型半胱氨酸血症可能具有共同的机制,通过降低 HDL 的生成加速 AD 的发病机制。

相似文献

1
Homocysteine, another risk factor for Alzheimer disease, impairs apolipoprotein E3 function.
J Biol Chem. 2010 Dec 3;285(49):38382-8. doi: 10.1074/jbc.M110.146258. Epub 2010 Oct 1.
2
Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
J Neurosci. 2019 Sep 11;39(37):7408-7427. doi: 10.1523/JNEUROSCI.2994-18.2019. Epub 2019 Jul 22.
3
Apolipoprotein-E forms dimers in human frontal cortex and hippocampus.
BMC Neurosci. 2010 Feb 20;11:23. doi: 10.1186/1471-2202-11-23.
5
Apolipoprotein E4 inhibits γ-secretase activity via binding to the γ-secretase complex.
J Neurochem. 2023 Mar;164(6):858-874. doi: 10.1111/jnc.15750. Epub 2023 Jan 15.
10
Evidence for differential effects of apoE3 and apoE4 on HDL metabolism.
J Lipid Res. 2002 Nov;43(11):1881-9. doi: 10.1194/jlr.m200172-jlr200.

引用本文的文献

1
Multi-functional role of apolipoprotein E in neurodegenerative diseases.
Front Aging Neurosci. 2025 Jan 29;17:1535280. doi: 10.3389/fnagi.2025.1535280. eCollection 2025.
2
Homocysteine, neurodegenerative biomarkers, and APOE ε4 in neurodegenerative diseases.
Alzheimers Dement. 2025 Jan;21(1):e14376. doi: 10.1002/alz.14376. Epub 2024 Nov 19.
3
Cholesterol Regulates Exosome Release in Cultured Astrocytes.
Front Immunol. 2021 Oct 14;12:722581. doi: 10.3389/fimmu.2021.722581. eCollection 2021.
5
Characteristics of TCM Constitution and Related Biomarkers for Mild Cognitive Impairment.
Neuropsychiatr Dis Treat. 2021 Apr 20;17:1115-1124. doi: 10.2147/NDT.S290692. eCollection 2021.
6
Expression of miR-28-3p in patients with Alzheimer's disease before and after treatment and its clinical value.
Exp Ther Med. 2020 Sep;20(3):2218-2226. doi: 10.3892/etm.2020.8920. Epub 2020 Jun 22.
7
Homocysteine Induces Inflammation in Retina and Brain.
Biomolecules. 2020 Mar 3;10(3):393. doi: 10.3390/biom10030393.
8
Deciphering the Link Between Hyperhomocysteinemia and Ceramide Metabolism in Alzheimer-Type Neurodegeneration.
Front Neurol. 2019 Jul 31;10:807. doi: 10.3389/fneur.2019.00807. eCollection 2019.

本文引用的文献

4
apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain.
J Clin Invest. 2008 Dec;118(12):4002-13. doi: 10.1172/JCI36663. Epub 2008 Nov 13.
5
ApoE promotes the proteolytic degradation of Abeta.
Neuron. 2008 Jun 12;58(5):681-93. doi: 10.1016/j.neuron.2008.04.010.
6
Hyperhomocysteinemia and Alzheimer's disease: A systematic review.
Arch Gerontol Geriatr. 2009 May-Jun;48(3):425-30. doi: 10.1016/j.archger.2008.03.009. Epub 2008 May 13.
8
Apolipoprotein E4 in macrophages enhances atherogenesis in a low density lipoprotein receptor-dependent manner.
J Biol Chem. 2007 Mar 16;282(11):7817-24. doi: 10.1074/jbc.M610712200. Epub 2007 Jan 18.
9
Apolipoprotein E polymorphism, age and coronary heart disease.
Ageing Res Rev. 2007 Aug;6(2):94-108. doi: 10.1016/j.arr.2006.11.001. Epub 2006 Dec 20.
10
Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels.
Neurobiol Dis. 2006 Jun;22(3):651-6. doi: 10.1016/j.nbd.2006.01.005. Epub 2006 Mar 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验